3 active not recruiting, 2 not yet recruiting, 1 recruiting. 6 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Active not recruiting 3, Not yet recruiting 2, Recruiting 1 |
| Phase 1 | 2 | Active not recruiting 1, Recruiting 1 |
Follow AskBio Inc: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of AB-1005 Gene Therapy in Japanese Adults With Moderate Parkinson's Disease (J-REGENERATE-PD) AB-1005 - Parkinson Disease | Phase 2 | Not yet recruiting | Bayer | 8 | 2027-01-25 | 2026-07-29 |
| Open-Label, Multi-Stage Study to Optimize the Intraputaminal Administration of AB-1005 Using a Prescriptive Infusion Algorithm (PIA) Prescriptive Infusion Algorithm, AB-1005 - PARKINSON DISEASE (Disorder) | Phase 2 | Not yet recruiting | AskBio Inc | 18 | 2026-11-01 | 2026-10-29 |
| A Study to Evaluate Safety, Tolerability, and Efficacy of AB-1009 Gene Therapy (GAA Gene) in Adult Participants With Late-Onset Pompe Disease (PROGRESS-GT LOPD) AB-1009 (GAA Gene) - Pompe Disease (Late-onset), Pompe Disease Late-Onset | Phase 1 / Phase 2 | Recruiting | AskBio Inc | 12 | 2026-04-15 | 2026-10-13 |
| A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD) AAV2-GDNF gene therapy, control surgery - Parkinson Disease | Phase 2 | Active not recruiting | AskBio Inc | 127 | 2024-06-11 | 2026-10-01 |
| Phosphatase Inhibition by Intracoronary Gene Therapy in Subjects With Non-Ischemic NYHA Class III Heart Failure AB-1002 - Congestive Heart Failure | Phase 2 | Active not recruiting | AskBio Inc | 150 | 2023-10-20 | 2025-12-03 |
| A Study to Evaluate the Safety of AB-1003 (Previously LION-101) in Subjects With Genetic Confirmation of LGMD2I/R9 (Part1) AB-1003 dose level 1, AB-1003 dose level 2, Placebo - Limb Girdle Muscular Dystrophy, Limb-Girdle Muscular Dystrophy Type 2 | Phase 1 / Phase 2 | Active not recruiting | AskBio Inc | 9 | 2023-05-15 | 2026-08-26 |
Parkinson Disease (3) · Glycogen Storage Disease (1) · Glycogen Storage Disease Type II (1) · Heart Failure (1) · Limb-girdle muscular dystrophy type 2A (1) · Lysosomal Storage Diseases (1) · Muscular Dystrophies (1) · Muscular Dystrophies, Limb-Girdle (1) · Muscular Dystrophy, Limb-Girdle, Type 2I (1) · Neuromuscular Diseases (1)
Biological Products (1) · Genetic Therapy (1) · alpha-Glucosidases (1)
United States (5) · Germany (2) · Poland (2) · United Kingdom (2) · Austria (1) · Belgium (1) · Bulgaria (1) · Canada (1) · Hungary (1) · Japan (1) · Netherlands (1) · Romania (1) · Spain (1)